期刊文献+

小鼠端粒酶蛋白亚单位重组腺病毒载体的构建及鉴定 被引量:2

Construction and Identification of Mouse Telomerase Reverse Transcriptase Recombinant Adenovirus Vector
下载PDF
导出
摘要 目的构建小鼠端粒酶蛋白亚单位(mousetelomerasereversetranscriptase,mTERT)基因重组腺病毒载体,为下一步研究其体外表达和动物实验研究提供基础。方法从肝癌细胞中提取总RNA,采用RT-PCR技术扩增mTERT的基因编码区序列,将序列定向克隆至真核表达载体pAC,将此表达质粒与腺病毒重组质粒pJM17共同转染293细胞,经同源重组产生重组腺病毒载体Ad-mTERT,纯化后的重组腺病毒载体Ad-mTERT在293细胞大量扩增并通过氯化铯密度梯度离心法纯化,测定病毒滴度。结果PCR及酶切证实:mTERTDNA正确克隆到穿梭质粒pAC中,带mTERTDNA的表达盒成功重组到腺病毒载体基因组E1A缺失区,并在293细胞中成功包装出具有感染活性的重组腺病毒Ad-mTERT。结论成功构建了小鼠TERT基因重组腺病毒载体,为研究其用于肿瘤的基因治疗奠定基础。 [Objective ] To construct the recombinant adenovirus vector expressing the mouse telomerase reverse transcriptase (mTERT) and provide the basis for further experiments in vivo and in vitro. [Methods] The cDNA of mTERT was amplified by RT-PCR. After purified, the gene fragment was cloned into a vector pAC. Recombinant adenovirus plasmid pAC-mTERT was co-transfected with pJM17 into 293 packaging cells and replication-deficient recombinant adenovirus Ad-mTERT by homologous recombination. The Ad-mTERT recombinant adenovirus was efficiently duplicated in 293 cells and was purified by CsCl density centrifugation and titer was measured. [Results] The recombinant plasmid was identified by PCR and digest with restriction enzyme. The recombinant adenovirus carrying mTERT gene was identified by PCR amplification. [Conclusion] The mouse TERT recombinant adenovirus vector was successfully constructed. The study lays foundation for tumor gene therapy by mTERT.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2006年第1期11-14,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 国家重点基础研究发展计划(973计划)基金资助项目(2003CB515507)
关键词 小鼠端粒酶蛋白亚单位 重组腺病毒载体 mouse telomerase reverse tranacriptase recombinant adenovirus vector
  • 相关文献

参考文献8

  • 1POOLE J C,ANDREWS L G,TOLLEFSBOL T O.Activity,function,and gene regulation of the catalytic subunit of telomerase(hTERT)[J].Gene,2001,269(1-2):1-12.
  • 2DUCREST A L,SZUTORISZ H,LINGNER J,et al.Regulation of the human telomerase reverse transcriptase gene[J].Oncogene,2002,21(4):541-552.
  • 3HARLEY C B.Telomerase is not an oncogene[J].Oncogene,2002,21(4):494-502.
  • 4DOYLE L A,HIGHSMITH W E.Telomerase as a diagnostic and therapeutic target for cancer[J].Expert Rev Anticancer Ther,2002,2(2):217-225.
  • 5TAKEUCHI H,KANZAWA T,KONDO Y,et al.Combination of caspase transfer using the human telomerase reverse transcriptase promoter and conventional therapies for malignant glioma cells[J].Int J Oncol,2004,25(1):57-63.
  • 6VONDERHEIDE R H,HAHN W C,SCHULTZE J L,et al.The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes[J].Immunity,1999,10(6):673-679.
  • 7ALDEN T D,PHTMAN D D,BERES E J,et al.Percutaneous spinal fusion using bone morphogenetie protein gene therapy[J].J Neurosurg,1999,90(1 Suppl):109-114.
  • 8LATTERMANN C,OXNER WM,XIAO X,et al.The adeno associated viral vector as a strategy for intradiscal gene transfer in immune competent and pre-exposed rabbits[J].Spine,2005,30(5):497-504.

同被引文献14

  • 1陕声国,张端莲,余瑛,陕光,唐甜,杨勇,熊颜娥,李红.血管瘤组织中端粒酶逆转录酶基因表达与端粒酶活性的关系[J].中华实验外科杂志,2004,21(6):661-663. 被引量:5
  • 2谢文练,褚忠华,韩金利,林天歆,许可慰,胡道琴.p53与端粒酶逆转录酶在膀胱移行上皮癌的表达和作用[J].中华实验外科杂志,2005,22(12):1557-1558. 被引量:4
  • 3Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med, 1992, 176:1693-1702.
  • 4Schultze JL, Maecker B, von Bergwelt-Baildon MS, et al. Tumour immunotherapy: new tools, new treatment modalities and new T- cell antigens. Vox Sang, 2001, 80:81-89.
  • 5Vonderheide RH, Domchek SM, Schuhze JL, et al. Vaccination of cancer patients against telomerase induces functional antitumor CD8 ^+ T lymphocytes. Clin Cancer Res, 2004, 10:828-839.
  • 6Parkhurst MR, Riley JP, Igarashi T, et al. Immunization of patients with the hTERT: 540-548 peptide induces peptide-reactive T lymphocytes that do not recognize tumors endogenously expressing telomerase. Clin Cancer Res, 2004, 10:4688-4698.
  • 7Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell, 2001, 106:263-266.
  • 8Engleman EG. Dendritic cell-based cancer immunotherapy. Semin Oncol, 2003, 30(3 Suppl 8):23-29.
  • 9Collins K, Mitehen JR. Telomemse in the human organism. Oneogene, 2002, 21:564-579.
  • 10Kyo S, Takakura M, Fujiwara T, et al. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci ,2008,99 : 1528-1538.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部